Back to Woodline Partners LP Woodline Partners LP

BCRXBCRX

Showing 2 of 11 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in BIOCRYST PHARMACEUTICALS INC

No. Woodline Partners exited its BCRX (Biocryst Pharmaceuticals) position in Q1 2025. Its Q4 2024 13F listed 450,199 shares worth $3.4M. Woodline Partners already held BCRX in its Q4 2019 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3.4M

Total Shares Change

-450,199

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$7.50
0
2024-Q4
New
450,199
—
$3.4M0.0%$7.52
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used